Elizabeth Crowley
Corporate Officer/Principal bij CELLDEX THERAPEUTICS, INC.
Vermogen: 171 365 $ op 30-04-2024
Profiel
Elizabeth Crowley is currently the Director at Horizons for Homeless Children, Inc. She is also currently serving as the Chief Product Development Officer & Senior VP at Celldex Therapeutics, Inc. She previously worked as the Director-Global Study Audit Management at Bayer Corp.
and as the Vice President-Development Operations at CuraGen Corp.
Ms. Crowley completed her undergraduate degree at Boston College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-06-2023 | 4 726 ( 0.01% ) | 171 365 $ | 30-04-2024 |
Actieve functies van Elizabeth Crowley
| Bedrijven | Functie | Begin |
|---|---|---|
| CELLDEX THERAPEUTICS, INC. | Corporate Officer/Principal | 01-01-2009 |
Horizons for Homeless Children, Inc.
 Horizons for Homeless Children, Inc. Miscellaneous Commercial ServicesCommercial Services Horizons for Homeless Children, Inc. operates as a day care center. The company was founded by Roger H. Brown, Michael Richard Eisenson and Linda A. Mason and is headquartered in Roxbury, MA. | Director/Board Member | - |
Eerdere bekende functies van Elizabeth Crowley
| Bedrijven | Functie | Einde |
|---|---|---|
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Corporate Officer/Principal | - |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Corporate Officer/Principal | - |
Opleiding van Elizabeth Crowley
| Boston College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CELLDEX THERAPEUTICS, INC. | Health Services |
| Bedrijven in privébezit | 3 |
|---|---|
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Health Technology |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
Horizons for Homeless Children, Inc.
Horizons for Homeless Children, Inc. Miscellaneous Commercial ServicesCommercial Services Horizons for Homeless Children, Inc. operates as a day care center. The company was founded by Roger H. Brown, Michael Richard Eisenson and Linda A. Mason and is headquartered in Roxbury, MA. | Commercial Services |
